Total Payments
$9,956
2022 Payments
$95.63
Companies
9
Transactions
30
Medicare Patients
928
Medicare Billing
$102,685
Payment Breakdown by Category
Other$3,185 (32.0%)
Travel$2,523 (25.3%)
Consulting$2,300 (23.1%)
Food & Beverage$1,949 (19.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,185 | 1 | 32.0% |
| Travel and Lodging | $2,523 | 11 | 25.3% |
| Consulting Fee | $2,300 | 1 | 23.1% |
| Food and Beverage | $1,949 | 17 | 19.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $3,701 | 13 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $3,406 | 4 | $0 (2017) |
| Celgene Corporation | $1,293 | 4 | $0 (2019) |
| PFIZER INC. | $1,096 | 4 | $0 (2017) |
| Alexion Pharmaceuticals, Inc. | $117.39 | 1 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $117.00 | 1 | $0 (2017) |
| Exelixis Inc. | $111.29 | 1 | $0 (2019) |
| AbbVie, Inc. | $81.67 | 1 | $0 (2017) |
| Biocompatibles, Inc. | $33.42 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $95.63 | 1 | Gilead Sciences, Inc. ($95.63) |
| 2020 | $96.85 | 1 | Gilead Sciences, Inc. ($96.85) |
| 2019 | $1,637 | 8 | Celgene Corporation ($1,293) |
| 2018 | $3,205 | 8 | Gilead Sciences, Inc. ($3,205) |
| 2017 | $4,922 | 12 | Merck Sharp & Dohme Corporation ($3,406) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/23/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $95.63 | General |
| Category: HCV | ||||||
| 02/18/2020 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $96.85 | General |
| Category: HCV | ||||||
| 11/09/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $75.51 | General |
| 10/05/2019 | Biocompatibles, Inc. | THERASPHERE-BIO (Device) | Food and Beverage | In-kind items and services | $33.42 | General |
| Category: INTERVENTIONAL ONCOLOGY | ||||||
| 09/20/2019 | Celgene Corporation | CC-90001 (Drug) | Travel and Lodging | Cash or cash equivalent | $570.00 | General |
| 09/20/2019 | Celgene Corporation | CC-90001 (Drug) | Travel and Lodging | Cash or cash equivalent | $354.90 | General |
| 09/20/2019 | Celgene Corporation | CC-90001 (Drug) | Food and Beverage | Cash or cash equivalent | $290.00 | General |
| 09/20/2019 | Celgene Corporation | CC-90001 (Drug) | Travel and Lodging | Cash or cash equivalent | $78.11 | General |
| 04/23/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $123.52 | General |
| 01/22/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $111.29 | General |
| Category: Oncology | ||||||
| 12/08/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Consulting Fee | Cash or cash equivalent | $2,300.00 | General |
| Category: HBV | ||||||
| 12/08/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Travel and Lodging | In-kind items and services | $348.96 | General |
| Category: HBV | ||||||
| 12/08/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Travel and Lodging | In-kind items and services | $250.00 | General |
| Category: HBV | ||||||
| 12/08/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Travel and Lodging | In-kind items and services | $137.45 | General |
| Category: HBV | ||||||
| 12/08/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: HBV | ||||||
| 12/08/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: HBV | ||||||
| 12/08/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Travel and Lodging | In-kind items and services | $44.00 | General |
| Category: HBV | ||||||
| 12/08/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: HBV | ||||||
| 12/14/2017 | Alexion Pharmaceuticals, Inc. | Kanuma (Drug) | Food and Beverage | In-kind items and services | $117.39 | General |
| Category: Immunology | ||||||
| 11/21/2017 | Bayer HealthCare Pharmaceuticals Inc. | Nexavar (Drug), Stivarga | Food and Beverage | In-kind items and services | $117.00 | General |
| Category: Oncology | ||||||
| 10/22/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $103.77 | General |
| 08/16/2017 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $81.67 | General |
| Category: Virology | ||||||
| 08/03/2017 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $381.86 | General |
| 08/03/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $349.85 | General |
| 08/03/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $204.05 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 173 | 263 | $54,330 | $16,350 |
| 2021 | 9 | 382 | 613 | $138,274 | $44,241 |
| 2020 | 7 | 373 | 600 | $143,333 | $42,094 |
Total Patients
928
Total Services
1,476
Medicare Billing
$102,685
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 72 | $18,936 | $6,013 | 31.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 42 | 89 | $16,287 | $5,006 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 44 | $11,924 | $3,132 | 26.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 37 | 37 | $3,256 | $1,249 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 21 | $3,927 | $950.51 | 24.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 97 | 262 | $68,906 | $21,862 | 31.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 62 | 106 | $19,398 | $6,074 | 31.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 43 | 46 | $16,100 | $5,006 | 31.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 70 | 85 | $7,480 | $4,479 | 59.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 46 | $12,466 | $3,364 | 27.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $8,673 | $2,252 | 26.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 17 | $3,179 | $752.48 | 23.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 13 | 14 | $616.00 | $325.38 | 52.8% |
| 91200 | Measuring the stiffness in the liver via elastography | Office | 2021 | 16 | 16 | $1,456 | $126.14 | 8.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 92 | 275 | $70,862 | $22,569 | 31.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 114 | 126 | $31,923 | $6,471 | 20.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 36 | 38 | $12,988 | $4,288 | 33.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 65 | 76 | $6,688 | $3,119 | 46.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 26 | 26 | $10,414 | $2,757 | 26.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 21 | 39 | $6,984 | $2,123 | 30.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 20 | $3,474 | $767.24 | 22.1% |
About Dr. Christopher Albers, MD
Dr. Christopher Albers, MD is a Gastroenterology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1558572503.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Albers, MD has received a total of $9,956 in payments from pharmaceutical and medical device companies, with $95.63 received in 2022. These payments were reported across 30 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3,185).
As a Medicare-enrolled provider, Albers has provided services to 928 Medicare beneficiaries, totaling 1,476 services with total Medicare billing of $102,685. Data is available for 3 years (2020–2022), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Hepatology, Transplant Hepatology
- Location Tampa, FL
- Active Since 05/24/2007
- Last Updated 06/08/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1558572503
Products in Payments
- ZEPATIER (Drug) $3,406
- Vemlidy (Drug) $3,205
- CC-90001 (Drug) $1,293
- Epclusa (Drug) $192.48
- Kanuma (Drug) $117.39
- Nexavar (Drug) $117.00
- Cabometyx (Drug) $111.29
- Mavyret (Drug) $81.67
- THERASPHERE-BIO (Device) $33.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Tampa
John Jacobs, M.d, M.D
Gastroenterology — Payments: $73,013
Gastroenterology $73,013
Dr. Renee Marchioni Beery, D.o, D.O
Gastroenterology — Payments: $66,910
Gastroenterology $66,910
Dr. Shaffer Mok, M.d, M.D
Gastroenterology — Payments: $35,137
Gastroenterology $35,137
Pushpak Taunk
Gastroenterology — Payments: $25,965
Gastroenterology $25,965
Dr. John Delgado, M.d, M.D
Gastroenterology — Payments: $22,410
Gastroenterology $22,410
Dr. Roland Shepard, Md, MD
Gastroenterology — Payments: $20,204
Gastroenterology $20,204